American Oncology Network, Inc.

American Oncology Network, Inc. (Nasdaq: AONC) is a blank-check company that priced its initial public offering in March 2021, with the final 424B4 prospectus filed with the SEC on March 11, 2021, under accession number 0001104659-21-035097. The vehicle was formed to pursue acquisition opportunities in the healthcare sector, specifically within oncology services and related provider businesses. AONC reflects a wave of SPAC activity in 2021 that focused on healthcare services as sponsors sought to capitalize on consolidation trends in specialty medicine. For complete filing history, deal status, sponsor details, and real-time SPAC analytics on AONC and thousands of other vehicles, sign up for full data access at SpacDesk.